Effect of indomethacin and selective cyclooxygenase-2 inhibitors on proteinuria and renal function in patients with AA type renal amyloidosis

Kahvecioglu S., Dilek K., Akdag I., Gullulu M., Demircan C., Ersoy A., ...Daha Fazla

NEPHROLOGY, cilt.11, sa.3, ss.232-237, 2006 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 11 Sayı: 3
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1111/j.1440-1797.2006.00562.x
  • Dergi Adı: NEPHROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.232-237
  • Anahtar Kelimeler: amyloidosis, celecoxib, cyclooxygenase-2, non-steroidal anti-inflammatory drugs, proteinuria, rofecoxib, GASTROINTESTINAL TOXICITY, CARDIOVASCULAR EVENTS, RHEUMATOID-ARTHRITIS, NEPHROTIC SYNDROME, COX-2 INHIBITORS, ROFECOXIB, RESOLUTION, CELECOXIB, NAPROXEN, RISK
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Aims: Because the cardiovascular system (CVS) side-effects of cyclooxygenase-2 (COX-2) selective inhibitors have recently been questioned, we aimed to compare the renal and haemodynamic effects of cyclooxygenase selective (celecoxib and rofecoxib) and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) (indomethacin) in patients with renal amyloidosis secondary to rheumatological diseases who required anti-inflammatory agents and are taking maximum tolerable dose of angiotensin-converting enzyme inhibitors.